ADR120S
web2ADR120S, identified in English by the company as ADR Biomedical Holdings, is a Japanese biomedi...
About
ADR120S, identified in English by the company as ADR Biomedical Holdings, is a Japanese biomedical holding company overseeing cell-therapy device development and regenerative medicine research. Its stated activities include managing group companies, developing and selling medical devices related to cell therapy, and researching cell-therapy technologies. The group’s technical platform uses adipose tissue-derived regenerative cells, and its website provides information on development programs and clinical trials. The company is listed on the Tokyo Stock Exchange Standard market under securities code 3750. This description refers to the company associated with the ADR120S name, not to a standalone medical product.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
ADR120S profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy